Understanding how CRISPR systems recognize and cut DNA and RNA
Molecular basis for CRISPR RNA-guided nucleic acid cleavage and DNA transposition
This study is looking at how certain bacteria use a tool called CRISPR to protect themselves from viruses, and by understanding this better, we hope to make gene editing safer and more precise for treating human diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Purdue University NIH-funded |
| Lab location | 1 site (West Lafayette, United States) |
| Project ID | NIH-10890768 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms of CRISPR-Cas systems, which are used by bacteria and archaea for adaptive immunity against invasive nucleic acids. By exploring newly discovered CRISPR systems, the research aims to improve the precision and safety of genome editing techniques. The approach includes structural and biochemical characterizations to understand how these systems target and cleave DNA and RNA. This knowledge could lead to safer applications in treating human diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic disorders that could potentially be treated with advanced genome editing techniques.
Not a fit: Patients with conditions that do not involve genetic mutations or those who are not candidates for genome editing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective genome editing therapies for various human diseases.
How similar studies have performed: Other research has shown promising results with CRISPR technology, indicating that this approach has the potential for significant advancements in genome editing.
Where this research is happening
West Lafayette, United States
- Purdue University — West Lafayette, United States (Active)
Researchers
- Principal investigator: Chang, Leifu — Purdue University
- Study coordinator: Chang, Leifu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.